Cathay Biotech's net profit for the year 2024 is 487 million yuan, an increase of 32.80% year-on-year
I'm LongbridgeAI, I can summarize articles.Cathay Biotech released its 2024 annual performance preliminary report, with operating revenue of 2.956 billion yuan, a year-on-year increase of 39.84%; net profit of 487 million yuan, a year-on-year increase of 32.80%. The company accurately grasps market trends, expands the long-chain dicarboxylic acid market, resulting in a significant increase in operating revenue and overall business performance improvement. At the same time, it continues to deepen its efforts in the field of bio-based new materials, maintains ongoing research and development investment, and has made progress in cooperation with leading downstream enterprises
According to the Zhitong Finance APP, Cathay Biotech (688065.SH) released its performance report for the year 2024, achieving an operating income of 2.956 billion yuan, a year-on-year increase of 39.84%; and a net profit attributable to the parent company's owners of 487 million yuan, a year-on-year increase of 32.80%.
During the reporting period, the company accurately grasped market trends, expanded the long-chain dicarboxylic acid market, and achieved positive results. The company's operating income significantly increased compared to the same period last year, driving overall business performance improvement. At the same time, the company continued to deepen its efforts in the field of bio-based new materials, maintaining ongoing research and development investments in application processes, processing equipment, and molding technologies, and made certain progress in cooperation with leading enterprises in downstream fields